Trial Profile
Pretreatment With Levosimendan In Patients Undergoing Left Ventricular Assist Device Implantation
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary) ; Dobutamine; Milrinone
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- 02 Apr 2020 Planned End Date changed from 31 Dec 2019 to 31 Dec 2021.
- 02 Apr 2020 Planned primary completion date changed from 1 Dec 2019 to 31 Dec 2020.
- 02 Feb 2019 Planned End Date changed from 31 Dec 2018 to 31 Dec 2019.